Biochemistry, Genetics and Molecular Biology
Genome-Wide Association Study
100%
Genetics
87%
Allele
64%
Single Nucleotide Polymorphism
61%
Genotyping
47%
Gene Expression
43%
Genome Wide Association Study
38%
Genetic Divergence
36%
Rare Variant
36%
Single-Nucleotide Polymorphism
32%
Polygenic Score
30%
Haplotype
29%
HLA-C
29%
Progenitor Cell
29%
Genetic Risk
26%
Genomics
26%
Sample Size
25%
Gene Ontology
25%
Exome
24%
Nervous System Development
21%
Transcription Factor
21%
Genetic Correlation
20%
Gene Expression Profiling
19%
Waist Circumference
16%
Folliculogenesis
14%
Case-Control Study
14%
Epidermolysis bullosa
14%
Genetic Predisposition
14%
Interferon Type I
14%
Pharmacogenomics
14%
Clinical Trial
14%
Binding Site
14%
Mediator
14%
Morphogenesis
14%
Mental Capacity
14%
Body Mass
14%
Loss of Function Mutation
14%
Coding Region
14%
HLA-B
14%
Differential Gene Expression
14%
BCL11A
14%
Cellular Differentiation
14%
Genetic Variation
12%
Embryonic Hemoglobin
11%
Neurexin
9%
Integrin
9%
Pharmacogenetic Testing
9%
Genetic Susceptibility
9%
Prevalence
8%
Biomarker Study
8%
Neuroscience
Gene Expression
60%
Anxiety Disorder
58%
Mental Disorder
47%
Major Depressive Disorder
45%
Antidepressant
43%
Progenitor Cell
43%
Genome-Wide Association Study
43%
Neurogenesis
36%
Transcriptomics
32%
Meta-Analysis
32%
Expression Analysis
32%
Alzheimer's Disease
29%
Cognitive Behavioral Therapy
29%
Bipolar Disorder
27%
Depressive Disorder
26%
In Vitro
25%
Cell Line
21%
Escitalopram
20%
Neural Stem Cell
16%
Vasoactive Intestinal Peptide
14%
Body Mass Index
14%
Neurotrophic Factor
14%
Messenger RNA
14%
Single-Nucleotide Polymorphism
14%
Genetic Variation
14%
Anxiety Comorbidity
14%
Hemoglobin F
14%
Negative Syndrome
14%
Comorbidity
14%
Positive Syndrome
14%
Protein Kinases
14%
Clozapine
14%
Cellular Differentiation
14%
HLA-C
14%
Adenosine Monophosphate
14%
Haplotype
14%
BCL11A
10%
Cell Proliferation
8%
Etiology of Schizophrenia
7%
Early Growth Response Factor 2
7%
Multigene Family
7%
Panic Disorder
7%
Alpha Integrin
7%
Calcium Signaling
7%
Neurexin
7%
Plexin
7%
Adalimumab
7%
Drosophila melanogaster
7%
Transcription Factors
7%
Molecular Processes
7%
Medicine and Dentistry
Psoriasis
43%
Meta-Analysis
33%
Genome Wide Association Study
30%
Clinical Feature
29%
Single Nucleotide Polymorphism
26%
Biological Marker
21%
Allele
18%
Diseases
18%
Body Mass Index
16%
Treatment Response
14%
Acneiform Eruption
14%
Cancer Mortality
14%
Malignant Neoplasm
14%
Global Disease Burden
14%
Vasoactive Intestinal Polypeptide
14%
Attention Deficit Disorder
14%
Hair Follicle
14%
Ovary Follicle Development
14%
Mediator
14%
Gene Expression Profiling
14%
Differential Gene Expression
14%
Cognitive Behavioral Therapy
14%
Morphogenesis
14%
Neurotrophic Factor
14%
Anxiety Disorder
14%
Clinical Trial
14%
Depressive Disorder
14%
Gene Expression
14%
Pharmacogenomics
14%
Antidepressant
14%
Disability Adjusted Life Years
12%
Odds Ratio
11%
UK Biobank
11%
Attributable Risk
9%
Neurexin
9%
Adalimumab
9%
Positive and Negative Syndrome Scale
9%
Negative Syndrome
9%
Positive Syndrome
9%
Immune Function
9%
Alpha Integrin
9%
Exome
9%
Pharmacogenetic Testing
9%
Medicine
7%
Acne Vulgaris
7%
Epidermolysis bullosa
7%
Dermatosis
7%
Major Depressive Episode
7%
Inflammatory Disorder
7%
Genetic Risk
7%